Sue Hughes

News

Do We Need Cardiovascular Risk Equations to Guide Statin Use?

Author:: Sue Hughes

Publish date: December 24, 2024

“I believe the new equations more accurately predict the risk of the current US population, but we need to be aware of what effect that may have on...

News

Silent Epidemic: Loneliness a Serious Threat to Both Brain and Body

Author:: Sue Hughes

Publish date: November 5, 2024

There is some evidence to suggest that isolation is more predictive of physical health outcomes, whereas loneliness is more predictive of mental he...

News

New Data on DOAC Initiation After Stroke in AF: Final Word?

Author:: Sue Hughes

Publish date: October 28, 2024

Early DOAC initiation was safe with a low rate of symptomatic hemorrhage, regardless of stroke severity.

News

Time to Revisit the Standard Treatment Approach in Children With MS?

Author:: Sue Hughes

Publish date: October 2, 2024

Only a few medications are licensed for pediatric use, indicating it may be time to reconsider the standard treatment approach for this patient pop...

News

New Hypertension Approach Hits Multiple Targets at Low Dose

Author:: Sue Hughes

Publish date: October 1, 2024

Ultralow-dose triple combinations can be a starting treatment followed by full-dose combinations for resistant hypertension .

News

Setbacks Identified After Stopping Beta-Blockers

Author:: Sue Hughes

Publish date: September 3, 2024

Though halting beta-blockers does not increase stroke, death, or MI, CV hospitalization rates, BP, and HR were increased.

News

New Blood Pressure Guidelines Simplified, Lower Treatment Target

Author:: Sue Hughes

Publish date: September 3, 2024

ESC releases simpler and more aggressive targets, 120 mm Hg to 129 mm Hg, in its latest hypertension guidelines.

News

Study Links Newer Shingles Vaccine to Delayed Dementia Diagnosis

Author:: Sue Hughes

Publish date: July 26, 2024

The current study made use of a “natural experiment” in the United States, which switched over from use of the live vaccine to the recombinant vacc...

News

New, Near-to-Market PCSK9s Could Help Patients Meet Cholesterol Targets

Author:: Sue Hughes

Publish date: July 25, 2024

New PCSK9 inhibitors are expected to be available soon, adding to patients’ options in reaching their goals to lower LDL.

News

Antidepressant Withdrawal Symptoms Much Lower Than Previously Thought

Author:: Sue Hughes

Publish date: June 6, 2024

About 15% of patients who discontinued antidepressant therapy had true discontinuation symptoms.

News

Niacin and CV Risk: Should Advice on Intake Change?

Author:: Sue Hughes

Publish date: March 21, 2024

Niacin may not be the culprit; it is proposed that niacin derivatives formed above an intake threshold may be drivers of vascular inflammation.

News

Methylphenidate Linked to Small Increase in CV Event Risk

Author:: Sue Hughes

Publish date: March 19, 2024

ADHD medication treatment linked to higher probability of increased risk for CV events, says study.

News

Phase 2 Results: Zerlasiran siRNA Drug Lowers Lp(a) by 90%

Author:: Sue Hughes

Publish date: March 18, 2024

At 36 weeks, siRNA reduced Lp(a) from baseline when compared to placebo, says company.

News

ACC Consensus Guidance on What’s New in HFrEF Treatment

Author:: Sue Hughes

Publish date: March 15, 2024

ACC provides three main updates in their guidance on the treatment of heart failure.

News

Plastic in Carotid Plaques Increased Risk of CV Event, Death

Author:: Sue Hughes

Publish date: March 8, 2024

New study finds patients with plastic particles within plaque in the carotid artery had a higher risk of both death and major CV events.